Amylyx’s ALS drug could face rejection in Europe

Amylyx’s ALS drug could face rejection in Europe

Source: 
BioPharma Dive
snippet: 

A committee advising the European Medicines Agency is signaling it may recommend against approval of Amylyx Pharmaceuticals’ ALS drug, the company said Tuesday.